Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 90.25
-3.65 (-3.89%)
Aug 21, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 83.13 billion as of August 21, 2026. Its market cap has decreased by -43.04% in one year.
Market Cap
83.13B
Enterprise Value
77.88B
Revenue
3.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
90.25
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 83.13B, an increase of 348.30%. That is a compound annual growth rate of 26.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 83.13B | -20.13% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 196.57B |
| Innovent Biologics | 171.05B |
| Sichuan Kelun-Biotech Biopharmaceutical | 125.13B |
| Sino Biopharmaceutical | 85.29B |
| RemeGen | 69.08B |
| Genscript Biotech | 64.21B |
| Biocytogen Pharmaceuticals (Beijing) | 58.22B |
| 3SBio | 41.59B |